lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway
Yan Liu,1 Xinyi Liu,1 Xiaofeng Zhang,2 Jinhu Deng,2 Jian Zhang,2 Hao Xing3 1Department of Otolaryngology & Head & Neck Surgery, Weihai Municipal Hospital of Shandong University, Weihai, Shandong Province 264200, People’s Republic of China; 2Department of Otolaryngology and...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/lncrna-dlx6-as1-promotes-proliferation-of-laryngeal-cancer-cells-by-ta-peer-reviewed-article-CMAR |
id |
doaj-974cac07a9f54286b9dee601fd626a36 |
---|---|
record_format |
Article |
spelling |
doaj-974cac07a9f54286b9dee601fd626a362020-11-25T03:00:40ZengDove Medical PressCancer Management and Research1179-13222020-04-01Volume 122685269553202lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 PathwayLiu YLiu XZhang XDeng JZhang JXing HYan Liu,1 Xinyi Liu,1 Xiaofeng Zhang,2 Jinhu Deng,2 Jian Zhang,2 Hao Xing3 1Department of Otolaryngology & Head & Neck Surgery, Weihai Municipal Hospital of Shandong University, Weihai, Shandong Province 264200, People’s Republic of China; 2Department of Otolaryngology and Head and Neck Surgery, Second Weihai Municipal Hospital Affiliated to Qingdao University, Weihai 264200, Shandong Province, People’s Republic of China; 3Department of Thyroid Surgery, Taian City Central Hospital, Taian 271099, Shandong Province, People’s Republic of ChinaCorrespondence: Hao XingDepartment of Thyroid Surgery, Taian City Central Hospital, No. 29 in Longtan Road, Taian 271099, Shandong Province, People’s Republic of ChinaTel +86-5388224161Email haoxing_surgery@yeah.netPurpose: Laryngeal cancer is the most prevalent tumor type in head and neck cancers. Early diagnosis is considered as an important strategy for improving prognosis. The lncRNA DLX6-AS1 has been shown to modulate tumor phenotypes in several types of cancer, but the role of DLX6-AS1 in laryngeal cancer and its concrete mechanisms are not clear.Methods: Tissue samples from laryngeal cancer patients and corresponding clinical data were used for detailed analysis. The laryngeal cancer cell lines HEp-2 and Tu-177 were studied. Cell proliferation, ROS production, mitochondrial respiratory function, intracellular and mitochondrial calcium influx were assessed. Western blotting, quantitative RT-PCR and luciferase assays were used to analyze the interactions. A xenografted tumor model was established to analyze the effects of DLX6-AS1 on tumor growth in vivo.Results: lncRNA DLX6-AS1 had increased expression in tumor tissues compared with adjacent normal tissues and in higher clinical stages compared with lower stages, which was associated with poor prognosis. In detail, DLX6-AS1 knockdown decreased cell proliferation and affected key mitochondrial metabolic parameters in both HEp-2 and Tu-177 cells. Moreover, DLX6-AS1 knockdown suppressed TRPC3-mediated mitochondrial calcium uptake and ROS production. Furthermore, miR-26a functioned as a link between these two molecules, as it could be absorbed by DLX6-AS1 and thus regulated the levels of TRPC3. Finally, the DLX6-AS1/miR-26a/TRPC3 axis modulated laryngeal cancer proliferation both in vitro and in vivo.Conclusion: This study provides new evidence that a novel lncRNA, DLX6-AS1, regulates mitochondrial calcium homeostasis, respiration and tumor proliferation via modulating the miR-26a/TRPC3 axis in laryngeal cancer.Keywords: laryngeal cancer, DLX6-AS1, miR-26a, mitochondria, TRPC3https://www.dovepress.com/lncrna-dlx6-as1-promotes-proliferation-of-laryngeal-cancer-cells-by-ta-peer-reviewed-article-CMARlaryngeal cancerdlx6-as1mir-26amitochondriatrpc3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Liu Y Liu X Zhang X Deng J Zhang J Xing H |
spellingShingle |
Liu Y Liu X Zhang X Deng J Zhang J Xing H lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway Cancer Management and Research laryngeal cancer dlx6-as1 mir-26a mitochondria trpc3 |
author_facet |
Liu Y Liu X Zhang X Deng J Zhang J Xing H |
author_sort |
Liu Y |
title |
lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway |
title_short |
lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway |
title_full |
lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway |
title_fullStr |
lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway |
title_full_unstemmed |
lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway |
title_sort |
lncrna dlx6-as1 promotes proliferation of laryngeal cancer cells by targeting the mir-26a/trpc3 pathway |
publisher |
Dove Medical Press |
series |
Cancer Management and Research |
issn |
1179-1322 |
publishDate |
2020-04-01 |
description |
Yan Liu,1 Xinyi Liu,1 Xiaofeng Zhang,2 Jinhu Deng,2 Jian Zhang,2 Hao Xing3 1Department of Otolaryngology & Head & Neck Surgery, Weihai Municipal Hospital of Shandong University, Weihai, Shandong Province 264200, People’s Republic of China; 2Department of Otolaryngology and Head and Neck Surgery, Second Weihai Municipal Hospital Affiliated to Qingdao University, Weihai 264200, Shandong Province, People’s Republic of China; 3Department of Thyroid Surgery, Taian City Central Hospital, Taian 271099, Shandong Province, People’s Republic of ChinaCorrespondence: Hao XingDepartment of Thyroid Surgery, Taian City Central Hospital, No. 29 in Longtan Road, Taian 271099, Shandong Province, People’s Republic of ChinaTel +86-5388224161Email haoxing_surgery@yeah.netPurpose: Laryngeal cancer is the most prevalent tumor type in head and neck cancers. Early diagnosis is considered as an important strategy for improving prognosis. The lncRNA DLX6-AS1 has been shown to modulate tumor phenotypes in several types of cancer, but the role of DLX6-AS1 in laryngeal cancer and its concrete mechanisms are not clear.Methods: Tissue samples from laryngeal cancer patients and corresponding clinical data were used for detailed analysis. The laryngeal cancer cell lines HEp-2 and Tu-177 were studied. Cell proliferation, ROS production, mitochondrial respiratory function, intracellular and mitochondrial calcium influx were assessed. Western blotting, quantitative RT-PCR and luciferase assays were used to analyze the interactions. A xenografted tumor model was established to analyze the effects of DLX6-AS1 on tumor growth in vivo.Results: lncRNA DLX6-AS1 had increased expression in tumor tissues compared with adjacent normal tissues and in higher clinical stages compared with lower stages, which was associated with poor prognosis. In detail, DLX6-AS1 knockdown decreased cell proliferation and affected key mitochondrial metabolic parameters in both HEp-2 and Tu-177 cells. Moreover, DLX6-AS1 knockdown suppressed TRPC3-mediated mitochondrial calcium uptake and ROS production. Furthermore, miR-26a functioned as a link between these two molecules, as it could be absorbed by DLX6-AS1 and thus regulated the levels of TRPC3. Finally, the DLX6-AS1/miR-26a/TRPC3 axis modulated laryngeal cancer proliferation both in vitro and in vivo.Conclusion: This study provides new evidence that a novel lncRNA, DLX6-AS1, regulates mitochondrial calcium homeostasis, respiration and tumor proliferation via modulating the miR-26a/TRPC3 axis in laryngeal cancer.Keywords: laryngeal cancer, DLX6-AS1, miR-26a, mitochondria, TRPC3 |
topic |
laryngeal cancer dlx6-as1 mir-26a mitochondria trpc3 |
url |
https://www.dovepress.com/lncrna-dlx6-as1-promotes-proliferation-of-laryngeal-cancer-cells-by-ta-peer-reviewed-article-CMAR |
work_keys_str_mv |
AT liuy lncrnadlx6as1promotesproliferationoflaryngealcancercellsbytargetingthemir26atrpc3pathway AT liux lncrnadlx6as1promotesproliferationoflaryngealcancercellsbytargetingthemir26atrpc3pathway AT zhangx lncrnadlx6as1promotesproliferationoflaryngealcancercellsbytargetingthemir26atrpc3pathway AT dengj lncrnadlx6as1promotesproliferationoflaryngealcancercellsbytargetingthemir26atrpc3pathway AT zhangj lncrnadlx6as1promotesproliferationoflaryngealcancercellsbytargetingthemir26atrpc3pathway AT xingh lncrnadlx6as1promotesproliferationoflaryngealcancercellsbytargetingthemir26atrpc3pathway |
_version_ |
1724696629837037568 |